
    
      Multi center, randomized, double-blind, parallel-group, therapeutic confirmatory study

      Primary Outcome Measure:

      The mean percent change of Non-HDL Cholesterol [Time Frame: from baseline at week 8]

      Secondary Outcome Measures:

      The achievement rate of LDL-C<100mg/dl, Non-HDL-C<130mg/dl [Time Frame: from baseline at week
      8] The mean percent change of LDL-C, HDL-C, TG, TC, Apo-AI, Apo-B [Time Frame: from baseline
      at week 4, 8] The mean percent change of Non-LDL-C/HDL-C, TC/HDL-C, LDL-C/HDL-C, Apo-B/Apo-AI
      [Time Frame: from baseline at week 4, 8] The mean percent change of Fibrinogen, hs-CRP [Time
      Frame: from baseline at week 4, 8] Safety evaluation [Time Frame: Treatment period and
      Extension period]
    
  